EMILY MISSIMER: Open Payments
NPI 1801031828 · ALDIE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $120 |
| Lundbeck LLC | 3 | $68 |
| Kestra Medical Technology Services, Inc. | 2 | $48 |
| ABBVIE INC. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: CAPLYTA, REXULTI, Assure WCD, VRAYLAR, FANAPT, ARISTADA, Dyanavel XR, Auvelity.
Industry payments across VA — which companies pay providers there.
